Tandem Diabetes Care Inc (TNDM)

Apr 21, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 21, 2025

Apr 19, 2025

When the Price of (TNDM) Talks, People Listen - news.stocktradersdaily.com

Apr 19, 2025

Apr 18, 2025

Reasons to Hold TNDM Stock in Your Portfolio for Now - MSN

Apr 18, 2025

Apr 15, 2025

RBC Capital Adjusts Tandem Diabetes (TNDM) Price Target Before Q - GuruFocus

Apr 15, 2025

Apr 15, 2025

RBC Cuts Price Target on Tandem Diabetes Care to $45 From $55, Keeps Outperform Rating - marketscreener.com

Apr 15, 2025

Apr 15, 2025

Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks - Yahoo Finance

Apr 15, 2025

Apr 11, 2025

Mizuho Initiates Coverage of Tandem Diabetes Care (LSE:0M0F) with Neutral Recommendation - Nasdaq

Apr 11, 2025

Apr 10, 2025

Tandem Diabetes Care (TNDM) Moves 7.6% Higher: Will This Strength Last? - Yahoo Finance

Apr 10, 2025

Apr 10, 2025

Mizuho Initiates Coverage of Tandem Diabetes Care (TNDM) with Neutral Recommendation - Nasdaq

Apr 10, 2025

Apr 10, 2025

Forecasting The Future: 9 Analyst Projections For Tandem Diabetes Care - Benzinga

Apr 10, 2025

Apr 10, 2025

Mizuho Initiates Tandem Diabetes Care at Neutral With $20 Price Target - marketscreener.com

Apr 10, 2025

Apr 09, 2025

Mizuho sets Tandem Diabetes stock at Neutral with $20 target By Investing.com - Investing.com Canada

Apr 09, 2025

Apr 09, 2025

Mizuho Initiates Coverage of Tandem Diabetes (TNDM) with Neutral Rating | TNDM Stock News - GuruFocus

Apr 09, 2025

Apr 09, 2025

Tubeless Insulin Pump Market Set to Witness Significant Growth - openPR.com

Apr 09, 2025

Apr 08, 2025

SEC Form DEF 14A filed by Tandem Diabetes Care Inc. - Quantisnow

Apr 08, 2025

Apr 08, 2025

Diabetes Management Technologies Market Size, Report by 2034 - Precedence Research

Apr 08, 2025

Apr 05, 2025

INVESTOR ALERT: Levi & Korsinsky Notifies Shareholders of Tandem Diabetes Care, Inc.(TNDM) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

Apr 05, 2025

Apr 04, 2025

Trump Tariffs Spare Drugmakers But Threaten Diabetes Device Industry - Benzinga

Apr 04, 2025

Apr 03, 2025

Tandem Diabetes Care stock hits 52-week low at $17.61 By Investing.com - Investing.com Australia

Apr 03, 2025

Apr 03, 2025

Tandem Diabetes Care To Announce First Quarter 2025 Financial Results - MarketScreener

Apr 03, 2025

Apr 03, 2025

Diabetes Tech Giant Tandem to Reveal Q1 Performance: Key Metrics Coming April 30 - Stock Titan

Apr 03, 2025

Apr 03, 2025

Medical Device Industry: Swept Up in the Tariffs, Diabetes Device Makers Bear the Brunt - Morningstar

Apr 03, 2025

Apr 03, 2025

Tandem Diabetes Care stock hits 52-week low at $17.61 - Investing.com

Apr 03, 2025

Apr 03, 2025

(TNDM) Investment Analysis - news.stocktradersdaily.com

Apr 03, 2025

Apr 01, 2025

Prudential Financial Inc. Purchases 39,784 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat

Apr 01, 2025

Mar 31, 2025

Tandem eyes Medicare coverage expansion for Type 2 - Yahoo Finance

Mar 31, 2025

Mar 28, 2025

Tandem Diabetes Care (TNDM) Down 8.9% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Mar 28, 2025

Mar 28, 2025

Artificial Pancreas Device System Market Projected To Witness - openPR

Mar 28, 2025

Mar 27, 2025

Tandem Diabetes Care Insiders Sell US$1.5m Of Stock, Possibly Signalling Caution - simplywall.st

Mar 27, 2025

Mar 26, 2025

Tandem Diabetes Care Inc (TNDM) Stock Price Down 4.6% on Mar 26 - GuruFocus

Mar 26, 2025

Mar 26, 2025

3 Reasons to Sell TNDM and 1 Stock to Buy Instead - Yahoo Finance

Mar 26, 2025

Mar 25, 2025

TNDM Stock Gains on the Commercial Launch of Control-IQ+ Technology - MSN

Mar 25, 2025

Mar 24, 2025

Stifel maintains Tandem Diabetes Care stock Buy rating, $60 target By Investing.com - Investing.com UK

Mar 24, 2025

Mar 23, 2025

(TNDM) Long Term Investment Analysis - Stock Traders Daily

Mar 23, 2025

Mar 21, 2025

Tandem Diabetes Gains 45.7% in a Year: What's Driving the Stock? - MSN

Mar 21, 2025

Mar 20, 2025

Tandem Diabetes at Oppenheimer Conference: Strategic Growth Insights - Investing.com

Mar 20, 2025

Mar 20, 2025

Tandem Diabetes at Oppenheimer Conference: Strategic Growth Insights By Investing.com - Investing.com Canada

Mar 20, 2025

Mar 20, 2025

Tandem announces publication of results from trial of Control-IQ+ AID technology - Yahoo Finance

Mar 20, 2025

Mar 20, 2025

Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data - Yahoo Finance

Mar 20, 2025

Mar 19, 2025

Tandem’s Control-IQ+ looks like a smart move for insulin-using T2D - BioWorld MedTech

Mar 19, 2025

Mar 19, 2025

Tandem reports A1C reduction in type 2 diabetes study By Investing.com - Investing.com South Africa

Mar 19, 2025

Mar 19, 2025

Tandem Diabetes Launches Next-Gen Automated Insulin Delivery Algorithm in U.S. - MPO-mag

Mar 19, 2025

Mar 19, 2025

Tandem reports A1C reduction in type 2 diabetes study - Investing.com India

Mar 19, 2025

Mar 19, 2025

Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes - Business Wire

Mar 19, 2025

Mar 19, 2025

Automated Insulin Delivery System Helps in Type 2 Diabetes - Medscape

Mar 19, 2025

Mar 19, 2025

Tubeless Insulin Pump Market Is Booming Worldwide | Medtronic - openPR

Mar 19, 2025

Mar 18, 2025

Tandem Diabetes Care launches Control-IQ+ automated insulin delivery technology in the US - Marketscreener.com

Mar 18, 2025

Mar 18, 2025

Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States - Enid News & Eagle

Mar 18, 2025